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Abstract
The Armitage test for linear trend in proportions can be modified using the multiple marginal model
approach for three regression models with arithmetic, ordinal and logarithmic dose scores simultane-
ously, to be powerful against a wide range of possible dose response relationships. Moreover, it can be
used for particular designs in the generalized linear (mixed) model for the three common effect sizes
odds ratio, risk ratio and risk difference. The related R package tukeytrend allows simple gener-
alizations, e.g. the analysis 2-by-k table data with a possible plateau shape or analysing overdispersed
proportions. The evaluation of further real data examples are available in a vignette to that R package.
1 Introduction
Armitage’s landmark paper Tests for linear trends in proportions [4] is widely used in the evaluation of
case-control genetic association studies [33], replicated toxicological bioassays [20], clinical dose find-
ing studies [17], exposure epidemiological table data [3], among others. This CA-test is a scores test for
weighted linear regression for the differences of proportions, organized in the simple 2-by-k table format
with quantitative dose levels Di. For the proportions πi is the common-formulated ordered alternative
hypothesis H1 : π1 < π2 <, ..., < πk|π1 < πk (against H0 : π1 = π2 =, ...,= πk) is somewhat under-
stated. Rather, it is tested exactly whether the slope parameter b of a linear regression differs from zero
H1 : b > 0. For k binomial variates yi with response probabilities pi in a randomized one-way layout
with dose levels Di using samples size ni the test statistics is:
TCA =
∑k
i=1 yi(Di −D)/
√
p(1 − p[
∑k
i=1 ni(Di −D)
2]
which is asymptotically univariate normal distributed. In principle it can be formulated as a two-sided or
one-sided test, but it is rare to restrict to a trend alternative, not knowing in which direction. Therefore the
one-sided version is considered here only. A Yates-type continuity correction or an exact unconditional
and conditional version [26] are available for small ni [19].
One issue with the CA-test is that it is considered as an order restricted test, sensitive to many
monotonous alternatives, but is defined for a linear alternative of the quantitative covariateDi only. This
becomes particularly clear in the genetic case-control association tests, where the CA test [10] is defined
for the additive mode of inheritance only, whereas the additional testing of dominant and recessive modes
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is more appropriate according to the genetic paradigm [12]. Of course, a linear regression test shows not
only power for exactly the linear alternative, but also in its neighborhood up to sublinear shapes. How-
ever, for supralinear profiles like a plateau shape, which is the recessive mode in genetics, the power is
comparatively low. Considering alternatively dose as a qualitative factor, the robust score-independent
test [32] or multiple contrast tests [8] can be recommended.
If the dose is still considered as a quantitative covariate, then the Tukey trend test [28] can be used,
namely simultaneous considering three regression models for the metametersDi, rank(Di) and log(Di),
[24], providing the joint distribution for this maximum test by means of multiple marginal models (mmm)
[22]. This requires the formulation of logistic regression models, but allows extensions in generalized lin-
ear (mixed) models - a second issue discussed here. Exactly where modifications of the original CA-test
are difficult, e.g. the adjustments against covariates, two-way to hierarchical designs, overdispersed pro-
portions instead of simple table data, multi-center studies, repeated measurements, multiple endpoints,
among others.
Although tests are divided into those for quantitative and qualitative modeling of dose, our approach
allows the simultaneous consideration of regression models (Di as covariate) and multiple contrasts (Di
as qualitative factor levels) simultaneously, a possible alternative for the controversial use of post-hoc
categorized exposure levels [5].
Not only the common used p-value for the CA-test is provided but also a compatible confidence in-
terval for a well-chosen effect size are available in the line of the recent p-value controversy [29, 2].
Notice, the CA-test is also used to claim temporal increasing (decreasing) incidences, e.g. the de-
creasing proportion of abnormal cervical smears in Korea cancer screening program from 2009 to 2014
[27], although dependent times contradicts the assumption of independent doses.
2 An asymptotic Tukey-type trend test for proportions
The primary idea of Tukey [28] is the simultaneous fitting of k = (1, 2, 3) low parametrized regression
models:
(1) logit(pi)
arithmetic = α1 + β1Di + ǫi,
(2) logit(pi)
ordinal = α1 + β2rank(Di) + ǫi
(3) logit(pi)
logarithmic = α1 + β3log(Di) + ǫi
and the selection of the best model by a maximum test. The joint inference for the three slope parameters
β1, β2, β3 for the three modelsm = 1, 2, 3 for the union-intersection test hypothesis H0 :
⋂
3
m=1 βm ≤
0 vs. HA :
⋃
3
m=1 βm > 0 can be achieved by the mmm approach [24].
Marginally fitting the model k, yields vectors with the parameter estimates δˆk,the corresponding stan-
dard error estimates σˆk, and (I ×Pk) matrices containing the standardized score contributions evaluated
at the ML estimates of the model parameters [22, 15], denoted by Ψˆk. Note that the M estimators θˆm
may be correlated, and thus test statistics in t = (t1, ..., tM ) may be correlated: models that use different
transformations or parametrization of the dose effect but are applied to the same response variable con-
tribute correlated test statistics, because an overall positive trend in the data will cause several or all of
the corresponding test statistics to deviate from 0. Further, models applied to different response variables
may yield correlated test statistics if the response variables are correlated. In the following, results of [22]
will be used to account for the correlation among test statistics: For larges samples, the covariance among
the estimators θˆ obtained from multiple marginal models can be estimated from the row vectors ψˆn of
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Ψˆ, Vˆ = 1/N
∑N
n=1 ψˆ
T
n ψˆn. Standardizing Vˆ by its diagonal elements yields an asymptotic estimator of
the correlation between theM test statistics of interest, Rˆ. Notice, this maximum-test is asymptotic only.
Using the object-oriented R language the realization of this approach is numerically simple: first
fitting a logistic regression by glm into an object m1, using the library tukeytrend to find the joint
distribution with the correlations between the three model yielding simultaneous confidence limits (or
adjusted p-value) for the slope (with have to be back-transformed into OR using expit.)
3 Modifications
3.1 Canonical and non-canonical link function in the GLM
Approaches for the three common effect sizes for proportions can be formulated: odds ratio (OR), risk
ratio (RR) and risk difference (RD). The logit is the canonical link in generalized linear model (GLM)
yielding to the log-odds ratio of slope as effect size. For small ni and/or parameters near to the boundary,
e.g. p0 = 0, the parameter estimates may be biased and the confidence interval do not control the level
[7]. Because of the pooling properties of multiple contrast tests [25], even the model will not converged
in such cases. Here an adjustment is recommended, such as add2 correction [1] yielding pseudo-score
intervals [16]. Because of a one-sided test on slope is of interested, we use here an add1 approach [23].
Risk difference (RD) estimates are available using the identity link in R’s GLMbasic functionwhereas
the number of iterations should be large chosen. Risk ratio estimates are available by the package
logbin using an EM-type algorithm [18].
Usually the effect size should be clear a-priori based on design, randomization and style of inter-
pretation. This is not always the case in the p-value-focused world, and therefore a maximum test over
these 3 link functions is proposed a trifle provocative. Using the multiple marginal model concept, such
a double maximum test is available for transformations ξ(pi) (and the 3 dose metameters) because the
data matrix is the same. As a result you get which model related link function and which dose metameter
is most in the alternative. Notice, these models are highly correlated, so the additional conservatism is
comparatively low with respect to the possibility of choosing the best model under error control.
This approach is demonstrated by simple 2-by-k-table data for incidence of squamous cell papilloma
in male B6C3F1 mice administered 0, 0.0875, 0.175, 0.35, or 0.70 mM acrylamide [6]:
Table 1: Example 2-by-k-table data
Dose 0 0.0875 0.175 0.35 0.70
No. papilloma 0 2 2 6 6
No. mice 46 45 46 47 44
The R-code is relatively simple using the R-package tukeytrend here for the log(OR) (see more details
in the vignette [14]):
library(tukeytrend)
swaOR <-glm(cbind(events+0.5,(n-events)+0.5)~dose, data=squam, family= binomial(link="logit"))
tuOR <- tukeytrendfit(swaOR, dose="dose", scaling=c("ari", "ord", "arilog"))
pOR <- summary(glht(model=tuOR$mmm, linfct=tuOR$mlf, alternative="greater"))
For the canonical link the model with min(p) is for the ordinal dose metameter (see Table 2) and the
corresponding OR (and its lower confidence limit) can be easily estimated: 1.70; [1.18, ]. This means that
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with a dose increase of rank 1, the OR for the tumor incidence increases by at least 118%. The optimal
model without a-priori model choice (Opt: RD) is for RD and log(Di), where the p-value of 0.0013 is
only slightly higher than for the a-priori selected model (0.00068).
Table 2: p-values for 4 different models: effect sizes OR, RD and RR, and the best of (OR,RR,RD)
Effect size Metameter Adj. p-value
OR ari 0.00833
OR ord 0.00614
OR log 0.00632
RD ari 0.00280
RD ord 0.00069
RD log 0.00068
RR ari 0.00591
RR ord 0.00454
RR log 0.00441
Opt:RD Opt:log 0.00131
3.2 Joint testing dose as quantitative covariate and qualitative factor
The mmm-approach allows maximum tests over any linear models, e.g. a joint test of Tukey-type and
Williams-type trend test [31], i.e. a regression-type and an ANOVA-type linear contrast model [24]. Two
contradictory aspects meet: increasing the conservativeness of the test by including 3 + (k − 1) single
tests (instead of only 3) and an almost balanced power behavior for any of sub-, supra- and linear profiles.
The power loss of this joint test against the Tukey-test is tolerable because these many models are highly
correlated [24]. It allows the interpretation of elementary confidence intervals (or p-values) for both the
slopes and the pooled contrasts. The latter is the essential advantage over a max-test including CA-trend
test and Williams-isotonic test [30] [21]. This joint test is particularly interesting for supra-linear curves,
e.g. a plateau effect, as it shows an average high quality for any shape [24]. As an example the number
of cured patients treated with 0, 1, 2, 4% flutrimazol in a clinical dose-finding study in acute vulvovaginal
candidosis [11] is used:
Table 3: Example 2-by-k-table data with a possible plateau shape
1 2 3 4
Dose 0 1 2 4
No. cured 12 22 22 20
No. patients 33 28 32 31
The GLM-object lmf is plugged into the tukeytrendfit function, containing both the three
regression models and the Williams contrast test [31]:
lmf <-glm(cbind(events,n-events)~dose, data=flutri, family= binomial(link="logit"))
TW <- tukeytrendfit(lmF, dose="dose",
scaling=c("ari", "ord", "arilog", "treat"), ctype="Williams")
ETW <- summary(glht(model=TW$mmm, linfct=TW$mlf, alternative="greater"))
While none of the regression models is in the alternative, the William multiple contrast test shows a
significant increase in the cure rate for the pooled doses in Table 4.
3.3 GLM and GLMM: overdispersed proportions
Although most trend tests on proportions based on simple 2-by-k table data, studies with replicated pro-
portions for each experimental unit within a group exist. Here overdispersion, i.e. variability between
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Table 4: Tukey Trend or Williams test (canonical link)
Dose Model Test statistics p-value
Quantitatively Tukey: arithm 1.7 0.14
Tukey: ord 2.0 0.07
Tukey: log 2.0 0.07
Qualitatively Williams: 0 vs. 4 2.2 0.044
Williams: 0 vs. 2+4 3.4 0.0013
Williams: 0 vs. 1+2+4 4.6 < 0.001
the individual proportions within a treatment group should be considered. Several approach are available
[13], here, quasi-binomial model in the GLM (using the quasibinomial(link="logit") link function)and
a generalized linear mixed model with a random factor for the between-units variability are used. As
an example the germination rates for seed Orobanche cernua cultivated in three dilutions of a bean root
extract in six replicates plates are used[9].
Table 5: Example data with replicated proportions
Dose Un-germinated Germinated
1.000 43 2
51 9
44 5
71 16
24 2
7 0
0.040 19 17
56 43
87 79
55 50
10 9
0.002 13 11
62 47
104 90
51 46
11 9
The quasibinomial logit link function in the standard GLM can be used, where its model is easily
plugged into the tukeytrendfit function.
oro<-glm(cbind(m,n) ~ dose, data=orob1, family=quasibinomial(link="logit"))
Exa17 <- tukeytrendfit(oro, dose="dose", scaling=c("ari", "ord", "log"))
EXA17<-summary(glht(model=Exa17$mmm, linfct=Exa17$mlf))
Alternatively a generalized mixed effect model can be used, whereas the penalized quasi-likelihood
approach; available via the function glmmPQL is particularly stable. The related code is more complex:
OrobD <- dosescalett(orob1, dose="dose", scaling=c("ari", "ord", "log"))$data
glari <- glmmPQL(fixed=cbind(m,n) ~ doseari, random = ~ 1 |plate,
family = binomial, data=OrobD)
glord <- glmmPQL(fixed=cbind(m,n) ~ doseord, random = ~ 1 |plate,
family = binomial, data=OrobD)
gllog <- glmmPQL(fixed=cbind(m,n) ~ doselog, random = ~ 1 |plate,
family = binomial, data=OrobD)
lari <- tukeytrend:::lmer2lm(glari)
lord <- tukeytrend:::lmer2lm(glord)
llog <- tukeytrend:::lmer2lm(gllog)
linf <- matrix(c(0,1), ncol=2)
ttf <- summary(glht(mmm("mari"=lari, "mord"=lord, "mlog"=llog),
mlf("mari"=linf, "mord"=linf, "mlog"=linf), alternative="less"))
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In either model, a strong significant decreasing germination rate according to the arithmetic dose
score results.
3.4 Further modifications
Using both mmm and GLMM approaches, trend tests on i) multiple binary endpoints, ii) multiple dif-
ferently scaled endpoints, iii) multinomial endpoints decomposed into correlated binary endpoints, iv)
adjustments against covariate(s), v) non-monotonic dose-response relationships with a downturn effect at
higher doses, vi) multi-center studies, vii) binary repeated measures, viii) cross-over designs are available,
see related examples in the vignette [14].
4 Conclusions
By using the multiple marginal models approach (mmm), the widely used CA-trend test can be modified
which is powerful versus multiple shapes of dose response relationships (not just linear) for numerous
special cases in GLMM for the three common effect sizes odds ratio, risk ratio and risk difference.
Examples for 2-by-k table data with a plateau shape and overdispersed proportions are discussed explic-
itly. More scenarios are given in a vignette to the R package tukeytrend [24].
The proposed approaches apply only asymptotically. In general, small sample sizes should generally be
avoided for discrete endpoints, if only because of insufficient power.
Acknowledgment: We thank Prof. Dr. Christian Ritz (University of Copenhagen) for the specific hints to
the mmm approach in GLM and GLMM.
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